• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Endosonics breaks ground at new site

Article

Intravascular ultrasound developer Endosonics broke ground thisweek on a new manufacturing facility in Rancho Cordova, CA. ThePleasanton, CA, vendor said that strong demand for its productsnecessitated the construction of the 44,000-square-foot

Intravascular ultrasound developer Endosonics broke ground thisweek on a new manufacturing facility in Rancho Cordova, CA. ThePleasanton, CA, vendor said that strong demand for its productsnecessitated the construction of the 44,000-square-foot facility,which will manufacture the company's Oracle and Five-64 catheters.Endosonics will continue to produce its current line of cathetersin Pleasanton.

In other news, Endosonics reported last month that its CardioVascularDynamics (CVD) subsidiary has signed an agreement with the vascularintervention group of Guidant to develop new perfusion angioplastycatheters. Guidant last year received an option for CVD's mechanicalangioplasty catheter (MAC) technology, and last month's agreementexercises that option.

As part of the deal, Guidant granted CVD exclusive rights tomarket Guidant's SmartNeedle products, which use Doppler ultrasound-guidedneedle technology to locate and access arteries and veins in patients.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.